Excellence in early and late phase clinical trials across an expansive range of therapeutic areas.
MAC brings together a diverse set of capabilities and research experience for the benefit of pharma, biotech and CROs. Our ability to recruit participants and conduct clinical trials with expertise across an extensive range of medical conditions sets us apart from other research organisations.
MAC EnVision® patient engagement solutions provide access to an extensive range of therapeutic areas.
Timeline Recovery: MAC was approached 12 months into the trial and recruited a significant number of patients.
This study ran across 4 countries (UK, Germany, Belgium and Poland). MAC randomized 49% of the patients.
MAC recruited more patients in this depression study that several larger countries.
In this study MAC randomised 67% of the total UK study population.
Timeline Recovery: The IMP was going out of date. MAC successfully delivered within timeframe (single site).
This complex in-patient clinical trial ran in 4 countries, but many sites did not recruit any patients.